News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

NCI-funded researchers are testing a new platform that blends statistical and deep learning models, giving you a fuller picture of the variants driving cancer progression.

Read this recently released collection of 13 studies to learn more about NCI’s Human Tumor Atlas Network (HTAN). You’ll gain insights into tumor development, progression, and treatment responses through advanced research methodologies and 3D tumor atlases.

Are you investigating structural variations underlying cancer-causing genes? NCI-funded researchers are testing a new algorithm that could help you track down both coding and non-coding cancer-causing genes.

Looking for new data sources for your machine learning model? NCI researchers combined data from dogs and people to identify risk factors for osteosarcoma.

Want to learn more about bioinformatics? Tap into these two newly published articles to see what some prominent researchers are saying about the field and where it’s headed.

Want to learn more about the noncoding regions of DNA that impact cancer and its resistance to treatment? A new NCI-funded computational tool called “MethNet” may help.

Looking for a new tool to help you better understand the genes that drive cancer? See how this NCI-funded tool called “HAPI” can help you spot structural changes linked to hijacked enhancers—bits of DNA that move from one location to another to boost overexpression of cancer-causing genes.

Apply for this NIH-supported opportunity to help advance the use of quantum computing to tackle real-world biomedical research problems, including cancer research.

Construction of the Advanced Research Projects Agency for Health’s (ARPA-H’s) BDF Toolbox program is well underway. ARPA-H has awarded contracts to nearly 20 teams—representing academia, nonprofits, and commercial organizations—who are tackling a broad range of projects, many of which are directly related to cancer research.

Thanks to funding from NCI’s Small Business Innovation Research program, a new tool recently received FDA clearance. See how this cyber device could help you with artificial intelligence (AI)-guided glioblastoma segmentation.